UroGen Pharma (URGN) Change in Inventory (2018 - 2026)

UroGen Pharma's Change in Inventory history runs 8 years deep, the most recent figure standing at $4.5 million for Q1 2026.

• Quarterly Change in Inventory rose 372.27% year-over-year to $4.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.3 million (up 3741.79% YoY) and the FY2025 annual result came in at $7.2 million, up 103.63% from the prior year.
• Change in Inventory was $4.5 million for Q1 2026 at UroGen Pharma, down from $8.1 million in the prior quarter.
• Across five years, Change in Inventory topped out at $8.1 million in Q4 2025 and bottomed at -$1.6 million in Q1 2025.
• A 5-year average of $997529.4 and a median of $199000.0 in 2024 frame the typical range for Change in Inventory.
• Annual changes were most pronounced in 2023 — Change in Inventory jumped 1600.0% — and 2025, when it plunged 332.16%.
• UroGen Pharma's Change in Inventory stood at -$283000.0 in 2022, then soared by 337.1% to $671000.0 in 2023, then jumped by 143.37% to $1.6 million in 2024, then jumped by 397.43% to $8.1 million in 2025, then sank by 45.13% to $4.5 million in 2026.
• Business Quant data shows URGN's Change in Inventory at $4.5 million in Q1 2026, $8.1 million in Q4 2025, and $1.2 million in Q3 2025.